by Fadi Agour | Aug 17, 2022 | Bankruptcy, Mass Torts
By Glenn Chappell, Leora Friedman and Allison Parr A New Jersey bankruptcy judge recently heard arguments on whether Johnson & Johnson can use the bankruptcy system to derail tens of thousands of lawsuits and shield its assets from potentially billions upon...
by Brady | Aug 17, 2022 | Mass Torts
By Erica Cirino We are no better protected from plasticized air outdoors than we are indoors. Minuscule plastic fibers, fragments, foam, and films are shed from plastic stuff and are perpetually floating into and free-falling down on us from the...
by Brady | Aug 17, 2022 | Mass Torts
By Libby Vish, Esq. | VP, Business Development As 2022 commences, we profile newsworthy litigations that saw significant movement and resolution, those emerging and others still on the horizon. The following are our Top 5 Mass Torts, starting with those closest to the...
by Brady | Aug 8, 2022 | Mass Torts
By Martha Rosenberg Anti-osteoporosis bone drugs such as Fosamax, Boniva, and Prolia have become a billion-dollar market for drugmakers thanks to aggressive marketing. To sell its “bisphosphonate” bone drug Fosamax, Merck began marketing the dangers of osteoporosis in...
by Brady | Aug 8, 2022 | Mass Torts
By Sara Stephens The U.S. Food and Drug Administration (FDA) has called out Philips Respironics for its inadequate efforts in notifying patients, suppliers, and healthcare providers of a massive recall of some of the company’s breathing assistance devices. On March...
Recent Comments